NCT05201508

Brief Summary

Paraesophageal hernia causes pain, heartburn, regurgitation, anemia and in extreme, life-threatening strangulation. For symptomatic patients, laparoscopic surgery is offered which includes hiatal defect closure and antireflux surgery. However, recurrence rates are high between 12 and 42%. In order to reduce recurrences, mesh has been used with various materials and techniques with conflicting results. Non-absorbable mesh has been linked with adverse events including erosion of esophageal wall. Traditionally used biological mesh materials are expensive and therefore problematic in routine use. Use of polyglactin (Vicryl®) mesh, which degrades in 6-8 week, has been reported in paraesophageal hernia surgery. Previously, no randomized controlled trial comparing sutures only and polyglactin mesh has been performed. In this trial, the aim was to randomize total of 110 patients to receive sutures only or mesh repair. Primary outcome was recurrence of paraesophageal hernia at 6 months after the repair based on computed tomography scan. Secondary outcomes included symptomatic recurrences, reoperation rate, quality of life, reoperations up to 20-years after surgery and use of proton pump inhibitors up to 20-years after surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
203mo left

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jan 2022Jan 2043

First Submitted

Initial submission to the registry

December 16, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 21, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

January 21, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
18 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2043

Expected
Last Updated

March 27, 2023

Status Verified

March 1, 2023

Enrollment Period

2.9 years

First QC Date

December 16, 2021

Last Update Submit

March 24, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Radiographic recurrence of PEH

    Computed tomography based recurrence after sutures only versus polyglactin mesh

    6 months after surgery

Secondary Outcomes (8)

  • Symptomatic versus asymptomatic recurrence rates

    6 months

  • Reoperation rate

    20 years

  • Health related quality of life based on score in esophago-gastric questionnaire (EORTC qlq-og25)

    6 months

  • Hiatal defect size related to recurrence rate

    6 months

  • BMI and the risk of recurrence

    6 months

  • +3 more secondary outcomes

Study Arms (2)

Sutures only

ACTIVE COMPARATOR

Traditional suture closure of hiatal defect

Procedure: Sutures only

Polyglactin mesh

EXPERIMENTAL

In addition to traditional sutures, key hole polyglactin mesh for hiatal defect closure.

Procedure: Polyglactin mesh

Interventions

Polyglactin mesh is used in keyhole manner to enforce hiatal closure

Polyglactin mesh
Sutures onlyPROCEDURE

Traditional hiatal closure with non-absorbable sutures.

Sutures only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years old
  • Type III-IV PEH with either radiologic or endoscopic confirmation
  • Scheduled for laparoscopic PEH repair
  • The informed consent is acquired

You may not qualify if:

  • Need for esophagus lengthening procedure (Collis gastroplasty)
  • Recurrent PEH
  • Emergency surgery
  • No written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oulu University Hospital

Oulu, 90220, Finland

RECRUITING

MeSH Terms

Conditions

Hernia, HiatalRecurrence

Condition Hierarchy (Ancestors)

Hernia, DiaphragmaticInternal HerniaHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Central Study Contacts

Olli Helminen, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Prospective open label randomized trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Adjunct professor

Study Record Dates

First Submitted

December 16, 2021

First Posted

January 21, 2022

Study Start

January 21, 2022

Primary Completion

December 31, 2024

Study Completion (Estimated)

January 1, 2043

Last Updated

March 27, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations